[1]TORRE LA，BRAY FI，SIEGEL RL，et al．Global cancer statistics，2012［J］．CA Cancer J Clin，2015，65(2):87-108.
[2]STOLNICU S，BARSAN I，HOANG L，et al．International endocervical adenocarcinoma criteria and classification(iecc):a new pathogenetic classification for invasive adenocarcino-mas of the endocervix［J］．Am J Surg Pathol，2018，42(2):214-226.
[3]HOLL K,NOWAKOWSKI AM,POWELL N,et al.Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias:Results from a European multinational epidemiological study［J］.Int J Cancer,2015,137(12):2858-2868.
[4]HODGSON A,HOWITT BE,PARK KJ,et al.Genomic characterization of Hpv-related and gastric-type endocervical adenocarcinoma:correlation with subtype and clinical behavior［J］.Int J Gynecol Pathol,2020,39(6):578-586.
[5] LU Z,CHEN J.Introduction of WHO classification of tumours of female reproductive organs,fourth edition［J］.Chinese Journal of Pathology,2014,43(10):649-650.
[6] ROJAS IQ.The cervical cancer prevention programme in Costa Rica［J］.E Cancer Medical Science,2015,9:578.
[7] LIN CQ,CUI JF,ZHANG X,et al.Human papillomavirus genotyping to predict the risk of cervical precancerous lesions or cancer in women with minor abnormal cytology in China［J］.Acta Radiol,2015,59(5):405-411.
[8]PARK SB,LEE JH,LEE HY,et al.Adenoma malignum of the uterine cervix:imaging features with clinicopathologic correlation［J］.Acta Rodiol,2013,54(1):113-120.
[9]WADA T，OHISHI Y，KAKU T，et al．Endocervical adenocarcinoma with morphologic features of both usual and gastric types:clinicopathologic and immunohistochemical analyses and high-risk hpv detection by in situ hybridization［J］．Am J Surg Pathol，2017，41(5):696-705.
[10] CARLETON C，HOANG L，SAH S，et al．A detailed immunohistochemical analysis of a large series of cervical and vaginal gastric-type adenocarcinomas［J］．Am J Surg Pathol，2016，40(5):636-644.
[11]JUNG H,BAE GE,KIM HM,et al.Clinicopathological and molecular differences between gastric-type mucinous carcinoma and usual-type endocervical adenocarcinoma of the uterine cervix［J］.Cancer Genomics Proteomics,2020,17(5):627-641.
[12]PIROG EC．Cervical adenocarcinoma:diagnosis of human papillomavirus-positive and human papillomavirus-negative tumors［J］．Arch Pathol Lab Med，2017，141(12):1653-1667.
[13]DANIELL J，PLAZZER JP，PERERA A，et al．An exploration of genotype-phenotype link between Peutz-Jeghers syndrome and STK11:a review［J］．Fam Cancer，2018，17(3):421-427.
[14]QIN Y,WEI J,LEI,et al．Forkhead box protein P1 is a useful marker for the diagnosis of mucinous minimal deviation adenocarcinoma of uterine cervix［J］．Ann Diagn Pathol，20l 4，18(4)：232-237．
[15]KWON SY，CHOE MS，LEE HW，et al．Minimal deviation adenocarcinoma of the cervix and tumorlets of sex-cord stromal tumor with annular tubules of the ovary in Peutz-Jeghers syndrome［J］．J Gynecol Oncol，2013，24(1):92-95.
[16]NEYAZ A,HUSAIN N,DEODHAR M,et al.Synchronous cervical minimal deviation adenocarcinoma,gastric type adenocarcinoma and lobular endocervical glandular hyperplasia along with stil in peutz-jeghers syndrome:eliciting oncogenesis pathways［J］.Turk Patoloji Derg,2019,35(3):247-253.
[17]SAIDA T，SAKATA A，TANAKA YO，et al． Clinical and MＲI characteristics of uterine cervical adenocarcinoma:its variants and mimics［J］．Korean J Ｒadiol，2019，20(3):364-377.
[18] TSUBOYAMA T，YAMAMOTO K，NAKAI G，et al．A case of gastrictype adenocarcinoma of the uterine cervix associated with lobular endocervical glandular hyperplasia:radiologicpathologic correlation［J］．Abdom Imaging，2015，40(3):459-465.
[19]ASAKA S,NAKAJIMA T,MOMOSE M,et al.Trefoil factor family 2 protein:a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.［J］.Virchows Arch,2019,474(1):79-86.
[20]WENG YAHAN，ZHAO HAIYANG，LIANG RUIMIN，et al．The role of immunohistochemistries in the clinicaI diagnosis of minimal deviation adenocarcinoma［J］．Modern Diagnosis & Treatment，2014(20)：4773-4775．
[21]SCHWOCK J,STAROVA B,KHAN ZF,et al.Cytomorphologic features of gastric-type endocervical adenocarcinoma in liquid-based preparations［J］.Acta Cytol,2021,65(1):56-66.
[22] KOH HH,JUNG YY,KIM HS.Clinicopathological characteristics of gastric-type endocervical adenocarcinoma misdiagnosed as an endometrial,ovarian or extragenital malignancy,or mistyped as usual-type endocervical adenocarcinoma［J］.In Vivo,2021,35(4):2261-2273.
[23]GREENLAND NY,WOLSKY RJ,DARRAGH TM,et al.Gastric-type endocervical adenocarcinoma and cervical cytology:Experience at a general hospital and review of the literature［J］.Cytopathology,2021,32(1):75-83.
[24]PARK CM，KOH HM，PARK S，et al．Gastric type mucinous endocervical adenocarcinoma of the uterine cervix:very rare and interesting case［J］．Obstet Gynecol Sci，2018，61(1):165-169.
[25]TALIA KL，MCCLUGGAGE WG．The developing spectrum of gastric-type cervical glandular lesions［J］．Pathol，2018，50(2):122-133.
[26]KOJIMA A，SHIMADA M，MIKAMI Y，et al．Chemoresistance of gastric-type mucinous carcinoma of the uterine cervix:a study of the sankai gynecology study group［J］． Int J Gynecol Cancer，2018，28(1):99-106.
[27]NISHIO S，MIKAMI Y，TOKUNAGA H，et al．Analysis of gastric-type mucinous carcinoma of the uterine cervix-An aggres-sive tumor with a poor prognosis:A multi-institutional study［J］．Gynecol Oncol，2019，153(1):13-19.
[28]TAKEUCHI S．Biology and treatment of cervical adenocarcinoma［J］．Chin J Cancer Ｒes，2016，28(2):254-262.
[29]GHOURAB S．Third-trimester transvaginal ultrasonography inplacenta previa:does the shape of the lower placental edge predict clinical outcome［J］．Ultrasound Obstet Gy-necol，2001，18(2):103-108.